Metabolic Biochemistry: Lipid, Amino Acid, Heme, One-Carbon, and Nucleotide Metabolism

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/76

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering the key enzymes, pathways, clinical disorders, and regulators discussed across Sessions 46 to 53 of Metabolic Biochemistry.

77 Terms

1
New cards

Triglycerides (TAGs)

Primary energy storage molecules in adipose tissue yielding ∼9 kcal/g\sim 9\,\text{kcal/g}, composed of a glycerol backbone esterified to three fatty acid chains via ester linkages.

2
New cards

Colipase

A protein cofactor that assists pancreatic lipase in the intestinal lumen to hydrolyze dietary triglycerides into 2-monoglycerides (2-MAG) and free fatty acids (FFAs).

3
New cards

Lipoprotein Lipase (LPL)

An enzyme anchored to the capillary endothelium in adipose, skeletal, and cardiac muscle that is activated by ApoC-II to hydrolyze triglycerides within circulating chylomicrons and VLDL into FFAs and glycerol.

4
New cards

Adipose Triglyceride Lipase (ATGL)

The rate-limiting intracellular lipolysis enzyme in adipocytes that hydrolyzes a triglyceride into diacylglycerol (DAG) and one free fatty acid; transcriptionally regulated by PPARγ\gamma and activated by cofactor CGI-58.

5
New cards

Hormone-Sensitive Lipase (HSL)

An intracellular adipocyte enzyme that hydrolyzes diacylglycerol to monoacylglycerol and one free fatty acid; activated via PKA phosphorylation (stimulated by catecholamines, glucagon, ACTH) and inactivated by insulin-stimulated dephosphorylation.

6
New cards

HMG-CoA Reductase

The rate-limiting enzyme in cholesterol biosynthesis located in the cytoplasm/ER that converts HMG-CoA into mevalonate utilizing 2 NADPH2\,\text{NADPH}.

7
New cards

SREBP2

A sterol regulatory element-binding transcription factor that, when intracellular sterols are low, is escorted by SCAP from the ER to the Golgi for proteolytic cleavage, releasing an active domain that upregulates HMG-CoA reductase and LDL receptor transcription.

8
New cards

ACAT (Acyl-CoA:Cholesterol Acyltransferase)

An intracellular enzyme that synthesizes cholesteryl esters from free cholesterol and fatty acyl-CoA for cellular storage in lipid droplets.

9
New cards

LCAT (Lecithin:Cholesterol Acyltransferase)

A plasma enzyme activated by ApoA-I on HDL that transfers a fatty acid from phosphatidylcholine to free cholesterol, forming hydrophobic cholesteryl esters inside HDL.

10
New cards

Cholesterol 7α\alpha-Hydroxylase (CYP7A1)

The rate-limiting enzyme in hepatic bile acid synthesis that converts cholesterol into primary bile acids (cholic acid and chenodeoxycholic acid).

11
New cards

Statins

Competitive inhibitors of HMG-CoA reductase structurally analogous to the HMG-CoA/mevalonate transition state, lowering intracellular hepatic cholesterol and upregulating hepatocyte LDL receptor expression.

12
New cards

Chylomicrons

The lowest-density (<0.95 g/mL< 0.95\,\text{g/mL}) lipoproteins composed of ∼90%\sim 90\% dietary triglycerides and containing ApoB-48, ApoA-I, ApoC-II, and ApoE, responsible for transporting dietary lipids to peripheral tissues.

13
New cards

VLDL (Very Low-Density Lipoprotein)

A lipoprotein (0.95−1.006 g/mL0.95 - 1.006\,\text{g/mL}) synthesized by the liver containing ∼60%\sim 60\% endogenous triglycerides and apoproteins ApoB-100, ApoC-II, and ApoE.

14
New cards

LDL (Low-Density Lipoprotein)

A cholesterol-rich lipoprotein (1.019−1.063 g/mL1.019 - 1.063\,\text{g/mL}) composed of ∼50%\sim 50\% cholesteryl esters and ApoB-100 that delivers cholesterol to peripheral tissues and the liver via LDLR endocytosis.

15
New cards

HDL (High-Density Lipoprotein)

The highest-density (1.063−1.210 g/mL1.063 - 1.210\,\text{g/mL}) lipoprotein containing ∼50%\sim 50\% protein (ApoA-I, ApoA-II, ApoC, ApoE) and phospholipids that mediates reverse cholesterol transport.

16
New cards

CETP (Cholesteryl Ester Transfer Protein)

A plasma protein that mediates the reciprocal exchange of cholesteryl esters from HDL for triglycerides from VLDL and IDL.

17
New cards

PCSK9

A circulating protein that binds cell-surface LDL receptors and directs them toward lysosomal degradation, preventing receptor recycling back to the hepatocyte membrane.

18
New cards

Familial Hypercholesterolemia (FH)

An autosomal dominant disorder most commonly caused by loss-of-function mutations in the LDLR gene, resulting in impaired hepatic LDL clearance, xanthomas, and premature atherosclerosis.

19
New cards

Pyridoxal Phosphate (PLP)

The active cofactor form of vitamin B6B_6 that forms a covalent Schiff base intermediate with amino acids during transamination reactions via a ping-pong, bi-bi mechanism.

20
New cards

Carbamoyl Phosphate Synthetase I (CPS-I)

The rate-limiting mitochondrial enzyme of the urea cycle that condenses free NH4+\text{NH}_4^+, HCO3−\text{HCO}_3^-, and 2 ATP2\,\text{ATP} into carbamoyl phosphate; strictly requires N-acetylglutamate (NAG) for allosteric activation.

21
New cards

N-Acetylglutamate (NAG)

An obligatory allosteric activator of carbamoyl phosphate synthetase I (CPS-I), synthesized by NAG synthase when stimulated by arginine, glutamate, and acetyl-CoA.

22
New cards

Glutamate Dehydrogenase

A mitochondrial enzyme in the liver and kidney that oxidatively deaminates glutamate using NAD+\text{NAD}^+ to release free NH4+\text{NH}_4^+ and regenerate α\alpha-ketoglutarate; activated by ADP/GDP and inhibited by ATP/GTP.

23
New cards

Transdeamination

The sequential pathway coupling aminotransferase transamination (transferring amino groups onto α\alpha-ketoglutarate to yield glutamate) with glutamate dehydrogenase oxidative deamination to liberate free ammonia for the urea cycle.

24
New cards

S-Adenosylmethionine (SAM)

The universal activated methyl donor formed from methionine and ATP, which yields S-adenosylhomocysteine (SAH) and ultimately homocysteine upon methyl group transfer.

25
New cards

Phenylketonuria (PKU)

An autosomal recessive aminoacidopathy caused by deficiency of phenylalanine hydroxylase (or BH4\text{BH}_4), resulting in elevated phenylalanine, musty body odor, hypopigmentation, and intellectual disability.

26
New cards

Maple Syrup Urine Disease (MSUD)

An inherited defect in the branched-chain α\alpha-ketoacid dehydrogenase complex that prevents degradation of leucine, isoleucine, and valine, resulting in neurotoxicity and sweet-smelling, maple-syrup-like urine.

27
New cards

Alkaptonuria

An inherited metabolic disorder caused by deficiency of homogentisate 1,2-dioxygenase, leading to homogentisic acid accumulation, urine that turns dark/black on standing, ochronosis, and severe arthritis.

28
New cards

ALA Synthase (ALAS)

The committed and rate-limiting mitochondrial enzyme of heme biosynthesis that condenses glycine and succinyl-CoA using PLP to form 5-aminolevulinic acid (ALA).

29
New cards

Ferrochelatase

The final mitochondrial enzyme of heme biosynthesis that inserts ferrous iron (Fe2+\text{Fe}^{2+}) into protoporphyrin IX to form heme; directly inhibited by lead.

30
New cards

Bilirubin Diglucuronide

The conjugated, water-soluble form of bilirubin generated in hepatocytes by UDP-glucuronosyltransferase (UGT1A1) attaching two glucuronic acid molecules, allowing excretion into bile.

31
New cards

Porphyrias

A group of disorders caused by partial enzyme deficiencies in heme synthesis: accumulation of early non-cyclic precursors (ALA, PBG) causes neurovisceral attacks, whereas accumulation of light-absorbing porphyrinogens causes cutaneous photosensitivity.

32
New cards

Dihydrofolate Reductase (DHFR)

An NADPH-dependent enzyme that reduces oxidized folate or dihydrofolate (FH2\text{FH}_2) to the functional one-carbon carrier tetrahydrofolate (THF / FH4\text{FH}_4).

33
New cards

Thymidylate Synthase

The enzyme that converts dUMP to dTMP by transferring and reducing a one-carbon unit from N5,N10-methylene-THFN^5,N^{10}\text{-methylene-THF}, oxidizing THF to FH2\text{FH}_2.

34
New cards

Folate Trap

The clinical condition in vitamin B12B_{12} deficiency where folate is locked irreversibly as N5-methyl-THFN^5\text{-methyl-THF} due to inactive methionine synthase, impairing purine and dTMP synthesis.

35
New cards

Methotrexate (MTX)

A folate analog that competitively inhibits human dihydrofolate reductase (DHFR), depleting intracellular FH4\text{FH}_4 and halting DNA replication in rapidly dividing cells.

36
New cards

Glutamine Phosphoribosyl Amidotransferase

The committed enzyme of de novo purine nucleotide synthesis that transfers an amino group from glutamine to PRPP to form 5'-phosphoribosyl 1'-amine; feedback-inhibited by AMP and GMP.

37
New cards

Carbamoyl Phosphate Synthetase II (CPS-II)

The cytosolic rate-limiting enzyme in de novo pyrimidine synthesis that uses glutamine, CO2\text{CO}_2, and 2 ATP2\,\text{ATP} to synthesize carbamoyl phosphate; inhibited by UTP and activated by PRPP.

38
New cards

Ribonucleotide Reductase (RR)

An enzyme that reduces ribonucleoside diphosphates (NDPs) to deoxyribonucleoside diphosphates (dNDPs) using the reducing power of thioredoxin.

39
New cards

Xanthine Oxidase

A purine catabolic enzyme that oxidizes hypoxanthine to xanthine, and xanthine to poorly soluble uric acid.

40
New cards

Lesch-Nyhan Syndrome

An X-linked recessive disorder caused by deficiency of HGPRT, impairing purine salvage and driving PRPP accumulation, de novo purine synthesis, hyperuricemia, choreoathetosis, and compulsive self-mutilation.

41
New cards

Allopurinol

A hypoxanthine structural analog that is metabolized to alloxanthine/oxypurinol to suicide-inhibit xanthine oxidase, treating hyperuricemia and gout by increasing excretion of soluble xanthine and hypoxanthine.

42
New cards

Triglycerides (TAGs)

Primary energy storage molecules composed of a glycerol backbone esterified to three fatty acid chains via ester linkages, yielding approximately 9 kcal/g9\,\text{kcal/g}, providing thermal insulation, and cushioning organs.

43
New cards

Lipoprotein Lipase (LPL)

An enzyme anchored to the capillary endothelium in adipose tissue and skeletal/cardiac muscle that is activated by ApoC-II to hydrolyze triglycerides within circulating chylomicrons and VLDL into free fatty acids and glycerol.

44
New cards

Adipose Triglyceride Lipase (ATGL)

The rate-limiting intracellular lipase in adipocytes that initiates lipolysis by converting triglycerides to diacylglycerol (DAG) and a free fatty acid; transcriptionally regulated by PPARγ\gamma and directly activated by the cofactor CGI-58.

45
New cards

Hormone-Sensitive Lipase (HSL)

An intracellular adipocyte enzyme that converts diacylglycerol to monoacylglycerol and a free fatty acid; activated via PKA-dependent phosphorylation (stimulated by catecholamines, glucagon, and ACTH) and inactivated via dephosphorylation (stimulated by insulin).

46
New cards

HMG-CoA Reductase

The committed, rate-limiting enzyme in cholesterol biosynthesis that reduces HMG-CoA to mevalonate; transcriptionally upregulated by SREBP2, allosterically/competitively inhibited by statins, and covalently inactivated by AMPK phosphorylation.

47
New cards

SREBP2

A transcriptional regulator that, under low sterol conditions, is escorted by SCAP from the ER to the Golgi for proteolytic cleavage, releasing an active N-terminal domain that enters the nucleus to upregulate transcription of HMG-CoA reductase and the LDL receptor.

48
New cards

Cholesterol 7α7\alpha-Hydroxylase (CYP7A1)

The rate-limiting enzyme of bile acid synthesis that catalyzes the conversion of cholesterol into primary bile acids (cholic acid and chenodeoxycholic acid).

49
New cards

Statins

Structural analogs of the HMG-CoA/mevalonate transition state that act as competitive inhibitors of HMG-CoA reductase, thereby depleting intracellular hepatic cholesterol, triggering SREBP2 activation, and upregulating hepatic LDL receptors.

50
New cards

Chylomicrons

The lowest-density lipoproteins (<0.95 g/mL< 0.95\,\text{g/mL}) containing ApoB-48, ApoA-I, ApoC-II, and ApoE that transport dietary triglycerides (∼90%\sim 90\%) from the intestines to peripheral tissues via lymphatic lacteals and the thoracic duct.

51
New cards

Very-Low-Density Lipoprotein (VLDL)

A liver-derived lipoprotein (0.95–1.006 g/mL0.95\text{--}1.006\,\text{g/mL}) containing ApoB-100, ApoC-II, and ApoE that packages and delivers endogenous liver-synthesized triglycerides (∼60%\sim 60\%) to peripheral tissues.

52
New cards

High-Density Lipoprotein (HDL)

The highest-density lipoprotein (1.063–1.210 g/mL1.063\text{--}1.210\,\text{g/mL}) containing ApoA-I, ApoA-II, ApoC, and ApoE (∼50%\sim 50\% protein) that mediates reverse cholesterol transport from peripheral tissues back to the liver and serves as an apoprotein reservoir.

53
New cards

Cholesteryl Ester Transfer Protein (CETP)

A plasma transport protein that transfers cholesteryl esters from HDL to VLDL and IDL in exchange for triglycerides.

54
New cards

PCSK9

A protein that binds to cell-surface LDL receptors and targets them for lysosomal degradation rather than recycling back to the cell membrane.

55
New cards

Familial Hypercholesterolemia (FH)

An autosomal dominant disorder caused primarily by loss-of-function mutations in the LDLR gene, resulting in impaired hepatic LDL clearance, marked elevations in plasma LDL-C, tendon xanthomas, corneal arcus, and premature atherosclerosis via macrophage foam cell accumulation.

56
New cards

Pyridoxal Phosphate (PLP)

The active coenzyme derived from vitamin B6\text{B}_6 that mediates transamination reactions via a ping-pong, bi-bi mechanism, forming a Schiff base intermediate and transiently converting to pyridoxamine phosphate (PMP) to transfer amino groups.

57
New cards

Carbamoyl Phosphate Synthetase I (CPS-I)

The rate-limiting mitochondrial enzyme of the urea cycle that condenses NH4+\text{NH}_4^+, HCO3−\text{HCO}_3^-, and 2 ATP2\,\text{ATP} to synthesize carbamoyl phosphate; obligatorily requires NN-acetylglutamate (NAG) as an allosteric activator.

58
New cards

NN-Acetylglutamate (NAG)

The obligatory allosteric activator of carbamoyl phosphate synthetase I (CPS-I); synthesized by NAG synthase, which is stimulated by arginine and high concentrations of glutamate and acetyl-CoA.

59
New cards

Transdeamination

The coupled metabolic pathway wherein aminotransferases collect nitrogen from amino acids into glutamate, followed by the oxidative deamination of glutamate by glutamate dehydrogenase to release free ammonia (NH4+\text{NH}_4^+) for the urea cycle.

60
New cards

Glutamate Dehydrogenase

A mitochondrial enzyme in the liver and kidney that oxidatively deaminates glutamate to release free NH4+\text{NH}_4^+ and regenerate α\alpha-ketoglutarate, using NAD+\text{NAD}^+ (for deamination) or NADPH\text{NADPH} (for amination); inhibited by ATP and GTP and activated by ADP and GDP.

61
New cards

SS-Adenosylmethionine (SAM)

The universal activated methyl donor formed from methionine and ATP; after transferring its methyl group, it forms SS-adenosylhomocysteine (SAH), which hydrolyzes to homocysteine and adenosine.

62
New cards

Phenylketonuria (PKU)

An inborn error of metabolism caused by a deficiency in phenylalanine hydroxylase (or its cofactor BH4\text{BH}_4), resulting in accumulation of phenylalanine and phenylketones, untreated intellectual disability, hypopigmentation, and a musty body odor.

63
New cards

Maple Syrup Urine Disease (MSUD)

An autosomal recessive disorder caused by a defect in the branched-chain α\alpha-ketoacid dehydrogenase complex, leading to the accumulation of leucine, isoleucine, valine, and their corresponding α\alpha-ketoacids, causing encephalopathy and a sweet, burnt-sugar urine odor.

64
New cards

Alkaptonuria

An autosomal recessive deficiency of homogentisate 1,2-dioxygenase, resulting in the accumulation of homogentisic acid, urine that turns dark/black on standing, ochronosis (blue-black cartilage pigmentation), and debilitating arthritis.

65
New cards

Homocystinuria

An inherited defect in cystathionine β\beta-synthase, causing elevated levels of homocysteine and methionine, thromboembolism, downward lens dislocation (ectopia lentis), and a marfanoid habitus.

66
New cards

δ\delta-Aminolevulinic Acid Synthase (ALA Synthase / ALAS)

The committed, rate-limiting mitochondrial enzyme of heme biosynthesis that condenses glycine and succinyl-CoA using PLP to form 5-aminolevulinic acid; ALAS1 (liver) is feedback-inhibited by heme/hemin (Fe3+\text{Fe}^{3+}), while ALAS2 (erythroid) is regulated by iron availability.

67
New cards

UDP-Glucuronosyltransferase (UGT1A1)

The hepatocyte enzyme that transfers two glucuronic acid molecules to hydrophobic unconjugated bilirubin, producing water-soluble bilirubin diglucuronide (conjugated bilirubin) for secretion into bile.

68
New cards

Acute Intermittent Porphyria (AIP)

An inherited disorder caused by porphobilinogen (PBG) deaminase deficiency, causing accumulation of non-cyclic precursors (ALA and PBG) that trigger neurovisceral attacks (abdominal pain, neuropsychiatric symptoms) without cutaneous photosensitivity.

69
New cards

Dihydrofolate Reductase (DHFR)

An enzyme that reduces dietary folate to dihydrofolate (FH2\text{FH}_2) and then tetrahydrofolate (FH4\text{FH}_4/THF) using NADPH; competitively inhibited by the antimetabolite drug methotrexate.

70
New cards

Thymidylate Synthase

An enzyme that converts dUMP to dTMP by transferring and reducing a one-carbon unit from N5,N10N^5,N^{10}-methylene-THF, simultaneously oxidizing THF to FH2\text{FH}_2; suicide-inhibited by FdUMP (a metabolite of 5-fluorouracil).

71
New cards

Folate Trap

A condition occurring in vitamin B12\text{B}_{12} deficiency where cellular folate becomes trapped as N5N^5-methyl-THF due to inactive methionine synthase, impairing purine and dTMP synthesis and causing megaloblastic anemia alongside neurological defects.

72
New cards

Glutamine Phosphoribosyl Amidotransferase

The committed enzyme of de novo purine synthesis that replaces the pyrophosphate group of PRPP with an amino group from glutamine to form 5'-phosphoribosyl 1'-amine; synergistically inhibited by AMP and GMP.

73
New cards

Carbamoyl Phosphate Synthetase II (CPS-II)

The cytosolic committed enzyme of de novo pyrimidine biosynthesis that consumes glutamine, CO2\text{CO}_2, and 2 ATP2\,\text{ATP} to form carbamoyl phosphate; activated by PRPP and ATP, and inhibited by UTP.

74
New cards

Hypoxanthine-Guanine Phosphoribosyltransferase (HGPRT)

A purine salvage enzyme that reacts PRPP with hypoxanthine to produce IMP and with guanine to produce GMP.

75
New cards

Ribonucleotide Reductase (RR)

An enzyme that reduces ribonucleoside diphosphates (ADP, GDP, CDP, UDP) directly to deoxyribonucleoside diphosphates (dNDPs) at the 2' carbon position, using electrons supplied by the protein cofactor thioredoxin.

76
New cards

Xanthine Oxidase

A catabolic enzyme that catalyzes the sequential oxidation of hypoxanthine to xanthine, and xanthine to uric acid; competitively inhibited by allopurinol.

77
New cards

Lesch-Nyhan Syndrome

An X-linked recessive disorder caused by HGPRT deficiency, leading to decreased purine salvage, PRPP accumulation, accelerated de novo purine synthesis, hyperuricemia, gout, dystonia, intellectual disability, and compulsive self-mutilation.